Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Bodenheimer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinics and Research in Hepatology and Gastroenterology|October 3, 2012
Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis CPetros C Benias, Kavitha Gopal, Henry Bodenheimer, et al.
Digestive Diseases and Sciences|April 9, 2008
Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosisCarmen M Stanca, Nancy Bach, Jorge Allina, et al.
The American Journal of Gastroenterology|January 16, 2003
Methotrexate therapy for primary biliary cirrhosisNancy Bach, Carol Bodian, Henry Bodenheimer, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donorsThomas D Schiano, Julio A Gutierrez, Jose L Walewski, et al.
Annals of Internal Medicine|March 5, 2004
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin doseStephanos J Hadziyannis, Hoel Sette, Timothy R Morgan, et al.
Gastrointestinal Endoscopy|August 23, 2006
Multicenter, randomized, controlled trial of virtual-reality simulator training in acquisition of competency in colonoscopyJonathan Cohen, Seth A Cohen, Kinjal C Vora, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinics and Research in Hepatology and Gastroenterology|October 3, 2012
Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis CPetros C Benias, Kavitha Gopal, Henry Bodenheimer, et al.
Digestive Diseases and Sciences|April 9, 2008
Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosisCarmen M Stanca, Nancy Bach, Jorge Allina, et al.
The American Journal of Gastroenterology|January 16, 2003
Methotrexate therapy for primary biliary cirrhosisNancy Bach, Carol Bodian, Henry Bodenheimer, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donorsThomas D Schiano, Julio A Gutierrez, Jose L Walewski, et al.
Annals of Internal Medicine|March 5, 2004
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin doseStephanos J Hadziyannis, Hoel Sette, Timothy R Morgan, et al.
Gastrointestinal Endoscopy|August 23, 2006
Multicenter, randomized, controlled trial of virtual-reality simulator training in acquisition of competency in colonoscopyJonathan Cohen, Seth A Cohen, Kinjal C Vora, et al.
Pageof 1